Previous studies demonstrated the involvement of NF-κB in Alzheimer’s disease (AD), Parkinson’s disease (PD), and ischemic stroke (Sivandzade et al., 2019), while NF-κB inhibition played a key role in reversing these disease pathologies. Here, NFKB1 is linked to Alzheimer disease.